Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial

Cómo citar

Rafael de la Torre, & Susana Solá, & Gimena Hernández, & Magı́ Farré, & Jesús Pujol, & Joan Rodríguez, & Josep M. Espadaler, & Klaus Langohr, & Aida Cuenca‐Royo, & Alessandro Príncipe, & Laura Xicota, & Nathalie Janel, & Silvina Catuara‐Solarz, & Gonzalo Sánchez‐Benavides, & Henri Bléhaut, & Iván Dueñas-Espín, & Laura del Hoyo, & Bessy Benejam, & Laura Blanco‐Hinojo, & Sebastián Videla, & Montserrat Fitó, & Jean Maurice Delabar, & Mara Dierssen (2016). Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial. https://doi.org/10.1016/s1474-4422(16)30034-5